emerge semaglutide Five Unexpected New Uses for GLP-1 Receptor Agonists Experience with Emerge Weight Loss?

Ann Pharmacother 2020;54:24753

To mitigate this limitation the researchers focused the analysis on patients whose HS treatments remained unchanged during the previous 12 months, in whom there was a statistically significant reduction in all outcomes at month six

We see this often, and it's easily preventable

What TRIUMPH-1 Is Actually Measuring TRIUMPH-1 is the obesity registration trial in Lilly's eight-trial TRIUMPH Phase 3 program

These findings were not attributed to variations in food intake, which implies that the observed results were mediated by alterations in metabolic processes [1]

(PubMed) Jackson PA, Forster JS, Bell JG, Dick JR, Younger I, Kennedy DO